DAPT score: predictive model of dual-antiplatelet therapy for acute cerebral infarction.

Abstract

This article analyzes factors which affect the prognosis of acute cerebral infarction (ACI) patients receiving a course of antiplatelet therapy with aspirin and (or) clopidogrel for 14days and proposes a simple grading scale to predict the clinical effectiveness of these drugs. We evaluated the association between ACI and risk factor (univariate analysis) on at day 14 post admission. Factors which potentially affected the 14-day prognosis of the patients were identified by logistic regression. A clinical grading scale, the DAPT score, was developed by weighing the independent predictors based on these factors. It is revealed that the factors which affected 14days prognosis univariate analysis included age ≥ 50years (P =0.007), diabetes (P =0.017), hypertension (P ≤ 0.001), hyperhomocysteinemia (P =0.001), and ipsilateral carotid artery stenosis ≥ 50% (P =0.019). Logistic regression also revealed that the factors which affected 14days prognosis included age ≥ 50years (P =0.007), hypertension (P ≤ 0.001), hyperhomocysteinemia (P =0.001), and ipsilateral carotid artery stenosis ≥ 50% (P =0.014).The assigned values of age ≥ 50years, Grade 1 hypertension, Grade 2 hypertension, Grade 3 hypertension, hyperhomocysteinemia, and ipsilateral carotid artery stenosis ≥ 50% were 1, 1, 2, 3, 1, and 1, respectively. We named this score (DAPT score) and it ranged between 0 and 6. Using 3 as a cutoff, the sensitivity was 90.6% and the specificity was 63.3%. The DAPT Score might be useful to for identifying with ACI who are suitable to receive aspirin combined with clopidogrel. Future large-scale, multi-center prospective studies are necessary.